Mark E. Hill
Impact in
Papers in
- Oncology 41
- Colorectal Cancer Treatments and Studies 29
- Cancer Treatment and Pharmacology 11
-
- Gastric Cancer Management and Outcomes 16
- Co-authors
- David Cunningham (46 shared papers)Andrew Richard Norman (26 shared papers)Samuel H. Preston (8 shared papers)Ira Rosenwaike (10 shared papers)Timothy Jay Price (9 shared papers)Ian Chau (16 shared papers)Paul J. Ross (15 shared papers)Josep M. Tabernero (3 shared papers)
- Journals
- British Journal of Cancer (14 papers)Journal of Clinical Oncology (13 papers)European Journal of Cancer (11 papers)Annals of Oncology (7 papers)Social Forces (4 papers)
- Partner nations
- United KingdomUnited StatesAustralia
In The Last Decade
Mark E. Hill
108 papers receiving 6.0k citations
Mark E. Hill's Hit Papers
Peers
Comparison fields: 5 of 156
- Oncology 2.9k
- Health 328
- Pulmonary and Respiratory Medicine 1.3k
- Hepatology 309
- Pathology and Forensic Medicine 687
Countries citing papers authored by Mark E. Hill
This map shows the geographic impact of Mark E. Hill's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark E. Hill with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark E. Hill more than expected).
Fields of papers citing papers by Mark E. Hill
This network shows the impact of papers produced by Mark E. Hill. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark E. Hill. The network helps show where Mark E. Hill may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark E. Hill, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 108 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Capecitabine Plus Oxaliplatin Compared With Fluorouracil and Folinic Acid As Adjuvant Therapy for Stage III Colon Cancer Hit paper breakdown → | 2011 | 615 |
| 2 | 2006 | 363 | |
| 3 | 2013 | 318 | |
| 4 | 2002 | 253 | |
| 5 | 1998 | 236 | |
| 6 | 2006 | 235 | |
| 7 | 2015 | 217 | |
| 8 | 2002 | 216 | |
| 9 | 2020 | 174 | |
| 10 | 2005 | 155 | |
| 11 | 2005 | 144 | |
| 12 | 1996 | 140 | |
| 13 | 2003 | 129 | |
| 14 | 2004 | 125 | |
| 15 | 2000 | 123 | |
| 16 | The Social Security Administration's Death Master File: the completeness of death reporting at older ages. | 2002 | 122 |
| 17 | 2005 | 118 | |
| 18 | 2002 | 117 | |
| 19 | 2005 | 117 | |
| 20 | 1997 | 116 |
About Mark E. Hill
Mark E. Hill is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Pathology and Forensic Medicine, Surgery and Health, having authored 108 papers that have together received 6.4k indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (29 papers), Gastric Cancer Management and Outcomes (16 papers), Cancer Treatment and Pharmacology (11 papers), Lymphoma Diagnosis and Treatment (10 papers), Esophageal Cancer Research and Treatment (8 papers), Insurance, Mortality, Demography, Risk Management (8 papers), Health disparities and outcomes (8 papers) and Colorectal and Anal Carcinomas (7 papers). The work is most often cited by research in Oncology (2.9k citations), Health (328 citations), Pulmonary and Respiratory Medicine (1.3k citations), Hepatology (309 citations) and Pathology and Forensic Medicine (687 citations). Mark E. Hill has collaborated with scholars based in United Kingdom, United States and Australia. Frequent co-authors include David Cunningham, Andrew Richard Norman, Samuel H. Preston, Ira Rosenwaike, Timothy Jay Price, Ian Chau, Paul J. Ross, Josep M. Tabernero, Jean Alfred Maroun and Daniel G. Haller. Their work appears in journals such as British Journal of Cancer, Journal of Clinical Oncology, European Journal of Cancer, Annals of Oncology and Social Forces.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.